These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19646974)

  • 1. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice.
    Kitaguchi H; Tomimoto H; Ihara M; Shibata M; Uemura K; Kalaria RN; Kihara T; Asada-Utsugi M; Kinoshita A; Takahashi R
    Brain Res; 2009 Oct; 1294():202-10. PubMed ID: 19646974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice.
    Yamada M; Ihara M; Okamoto Y; Maki T; Washida K; Kitamura A; Hase Y; Ito H; Takao K; Miyakawa T; Kalaria RN; Tomimoto H; Takahashi R
    PLoS One; 2011 Jan; 6(1):e16567. PubMed ID: 21305033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
    Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
    Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
    Salvadores N; Searcy JL; Holland PR; Horsburgh K
    Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
    Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
    Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral microemboli increase β-amyloid protein deposition, MMP-9, and GFAP expression in the Alzheimer`s model of APP/PS1 double transgenic mice.
    Ning M; Wu Y; Ni X; Zhao Y; Ling R
    Curr Neurovasc Res; 2014; 11(3):190-201. PubMed ID: 24962158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.
    Miao J; Xu F; Davis J; Otte-Höller I; Verbeek MM; Van Nostrand WE
    Am J Pathol; 2005 Aug; 167(2):505-15. PubMed ID: 16049335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.
    Liu H; Xing A; Wang X; Liu G; Li L
    Neurobiol Aging; 2012 Apr; 33(4):826.e31-42. PubMed ID: 21813211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.
    Irizarry MC; Soriano F; McNamara M; Page KJ; Schenk D; Games D; Hyman BT
    J Neurosci; 1997 Sep; 17(18):7053-9. PubMed ID: 9278541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.
    Irizarry MC; Cheung BS; Rebeck GW; Paul SM; Bales KR; Hyman BT
    Acta Neuropathol; 2000 Nov; 100(5):451-8. PubMed ID: 11045665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
    Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
    J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.
    Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX
    Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.
    Shi Q; Prior M; He W; Tang X; Hu X; Yan R
    J Neurosci; 2009 Jul; 29(29):9163-73. PubMed ID: 19625507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.
    DaRocha-Souto B; Scotton TC; Coma M; Serrano-Pozo A; Hashimoto T; Serenó L; Rodríguez M; Sánchez B; Hyman BT; Gómez-Isla T
    J Neuropathol Exp Neurol; 2011 May; 70(5):360-76. PubMed ID: 21487307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
    Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
    Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.